Patent · US Active

Anti-PD-1 antibodies and uses thereof

US10759859B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2017
Grant dateSep 1, 2020
Priority date—
Expiry dateJan 14, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A subset of humanized anti-PD-1 antibodies that inhibit binding of PD-L1 and PD-L2 to human PD-1. These binding proteins modulate the immune system through the manipulation of the PD-1 signaling pathway to treat immune dysfunctional disorders, including for example cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.